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1Abstract:
Traumatic brain injury (TBI) is a major cause of death and permanent disability in the 
United States. Approximately 1.7 million cases of TBI are reported annually. After an injury to 
the head, excessive glutamate, an excitatory neurotransmitter, is released into the extracellular 
fluid resulting in the excitotoxic death of neuronal tissue. Recent studies have suggested 
neurosteroids, may serve as an effective means by which to modulate excitotoxicity via the 
excitatory neurotransmitter alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA). Using mixed astrocyte-neuronal cell cultures (14-16 DIV) exposed to increasing 
concentrations of AMPA as the model for TBI, the experiments examined the effect of the 
neurosteroids, pregnenolone sulfate (PS) and dehydropiandrosterone sulfate (DHEAS), on the 
AMPA-mediated cell death using the lactate dehydrogenase (LDH) assay. In order to observe 
reactivity of neurosteroids on the specific receptor, AMPA, MK-801, an NMDA antagonist was 
incorporated into the experimental design. Experimental results concluded pregnenolone sulfate 
attenuates AMPA-mediated excitotoxicity in a dose-dependent manner, while 
dehydropiandrosterone sulfate provides a lesser degree of protection from excitotoxicity at 
higher concentrations in vitro. Neurosteroids may serve as a viable means by which to limit 
excitotoxic effects on the brain of an individual that has suffered from a TBI.
2Introduction:
Traumatic brain injury (TBI) is the leading cause of death and permanent disability in 
individuals under 45. Approximately 1.7 million cases of TBI are reported within the United 
States annually and, of those affected, over 50,000 die, 235,000 are hospitalized and 1.1 million 
are treated and released from an emergency room. (Polito et al., 2010) Due to the significant 
number of affected individuals, it is imperative to study and understand the mechanisms and 
impacts of TBI as a way to prevent, diagnose, and treat this condition. The recent realization of 
the prevalence of TBI associated with other diseases and symptoms has increased the study and 
development of treatment methods to decrease the severity of injury. Head injury accounts for 
2% of all deaths from all causes in the United States alone (McIntosh et al., 1996). Traumatic 
brain injury is caused by a blow or jolt to the head which results in the brain impacting into the 
skull or a penetrating head injury in which the function of the brain is disrupted. There are a 
variety of brain injury mechanisms which depend on the location and severity of the mechanical 
distortion applied to bone, blood vessels, and brain tissue. The initial trauma to the brain leads to 
immediate injury effects, including the death of brain tissue, and is later accompanied by 
secondary delayed injury including inflammation, receptor dysfunction, and negative free radical 
effects on surrounding tissue (Graham et al., 1995). The excitotoxin hypothesis of TBI proposes 
that secondary injury is mediated by elevated interstitial concentration of excitatory amino acids, 
such as glutamate and aspartate (Palmer et al., 1993). These delayed effects, causing ischemia, 
high intracranial pressure, and edema, are the targets for several treatment methods to reduce the 
severity of injury to the brain.
3During the period from 1995-2001, the leading causes of TBI were falls, accounting for 
28% of all reported cases, followed by motor vehicle accidents at 20%, and individuals struck by
an object accounted for 19% (Polito et al., 2010). The repercussions of brain injury may be 
temporary or may result in profound disability. Individuals affected by TBI are likely to 
experience signs or symptoms that appear in unpredictable ways throughout their lifetime.
Long-term effects of TBI include altered cognitive function, personality, behavior, and 
sensory and motor impairment. Studies regarding the biochemical mechanisms of injury to brain 
tissue have provided a great deal of insight into the pathology underlying patterns of post- 
traumatic tissue death and damage and may lead to developments reducing the mortality and 
morbidity of those affected with TBI (McIntosh et al., 1998; Leskiewicz et al., 2008; Shirakawa 
et al., 2005).
Research into TBI has significant implications in the treatment of veterans of the military 
operations in Iraq and Afghanistan. In a study conducted by Hill (2009), researchers assessed the 
diagnostic technique used by the Veterans Affairs (VA) association and applied the screening 
tool at the Walter Reed Medical Center to routinely test for TBI among soldiers injured as a 
result of explosive blasts, motor vehicles, falls, other explosions and gunshot wounds to the head. 
Traumatic brain injury was diagnosed in 62% of admitted soldiers in the three month period the 
test was conducted. Thirty-five percent of veterans that screened positive for TBI were diagnosed 
with service-connected, post-traumatic stress disorder (PTSD) in the polytrauma program. (Hill 
et al., 2009) The study concluded that soldiers suffering from mild to severe TBI via the VA TBI 
screening tool have higher rates of post-traumatic stress disorder. In a similar article by Polito et 
al. (2010), of the 1.64 million troops deployed as part of Operation Enduring Freedom and 
Operation Iraqi Freedom, 320,000 have sustained a brain injury, costing billions of dollars in
4health care (Polito et al., 2010). The paper also describes a diagnostic technique developed by the 
International Brain Research Foundation to more accurately diagnose TBI in affect individuals.
There are several mechanisms that cause trauma to the soft tissue of the brain. Traumatic 
brain injury is caused by a blow or jolt to the head and subsequent soft tissue damage caused by 
the physical strain of the impact of an object or of the brain against the skull. Regardless of the 
diverse means by which TBIs may occur, they all involve the nearly instant transfer of kinetic 
energy. Such impact will require either an absorption (acceleration) or release (deceleration) of 
kinetic energy by the head and brain (Shaw, 2002). The two main mechanisms of TBI include 
local skull distortion which propagates stress waves though the brain from the point of impact, 
and movement or distortion of the brain as a result of inertial or acceleration forces (McIntosh et 
al., 1996). Both of these mechanisms occur when the head is struck with an object or the brain 
moves within the skull as an indirect effect of contact or inertia, as in a motor vehicle accident 
(McIntosh et al., 1996)
Both types of mechanical force, contact and inertia, lead to soft tissue stress and strain 
which, in turn, causes focal and diffuse lesions to the brain. Focal lesions are injuries that are 
localized or restricted to specific areas. The most common causes of this type of injury include 
skull fracture, epidural hematoma, or bleeding between the inside of the skull and the dura layers 
of protective tissue covering the brain, cerebral contusions, and intracerebral hematoma, or 
bleeding within the macro or microvasculature throughout the brain (McIntosh et al., 1996). 
Diffuse lesions, or widespread injury of brain tissue, occur as a result of numerous focal injuries 
as well as diffuse axonal injury, caused by waves of physical stress that pass through the soft 
tissue as a result of the contact or inertial forces (McIntosh et al., 1996).
5A large force applied to a relatively small area on the surface of the skull will cause the 
skull to fracture and subsequently impact the underlying soft brain tissue. This type of injury, 
penetrating or depressed fracture, causes localized damage to the brain. Local distortion of the 
skull without fracture can deform the underlying brain tissue and create pressure gradients 
throughout the brain (McIntosh et ah, 1996). Elevated intracranial pressure has been 
hypothesized to be significant factors in production of cerebral contusions at the site of impact 
(McIntosh et al., 1996).
The inertial effects on the brain during injury occur via different mechanisms. The two 
major forms of acceleration injuries are rotational and translational (McIntosh et al., 1996). 
Rotational inertial injury, in which the brain is rotated and impacted into the skull, produces 
significant widespread tissue damage and strain throughout the brain relative to the direction of 
motion and location and presence of intracranial dural compartments. Translational injuries, in 
which the brain is directly impacted into the skull, produce intracranial pressure gradients and 
movement of the brain in relation to the skull. This type of injury is closely linked to cerebral 
contusions, hematomas, and histological lesions in the brainstem regions (McIntosh et al., 1996). 
Regardless of the precise role played by translation or rotation, it is clear that the energy 
imparted by acceleration of the head sets the brain in motion (Shaw, 2002). The brain is 
suspended in a protective layer of cerebrospinal fluid within the subarachnoid space which 
allows it some freedom to move. Due to its gelatinous and viscoelastic properties, it is relatively 
incompressible but readily distortable (Shaw, 2002).
Brain damage occurs in various areas throughout the soft tissue. Surface contusions and 
lacerations affect the gyri and have characteristic distribution affecting frontal poles, the ventral 
areas of frontal lobes, various areas of the cortex and, more specifically, the orbital gyri,
temporal lobes, and ventral aspect of the cerebellum (McIntosh et ah, 1996). Surface contusions 
are both problematic and life-threatening. Injuries to the prefrontal cortex of the brain may cause 
significant cognitive, behavioral, or executive function problems, because this area is responsible 
for higher-thought processes, decision making, and aspects of personality. Initially, the injured 
tissue is hemorrhagic and swollen which results in delayed effects of the injury (Shaw, 2002). 
There are several types of surface contusions. Fractural contusions occur at the site of fracture, 
coup contusions occur at the site of injury without fracture, countercoup contusions occur in the 
brain tissue diametrically opposite of the point of impact, herniation syndrome usually involves 
medial elements of the temporal lobes when brain tissue forces the deformation of other brain 
tissue, and gliding contusions describe hemorrhagic lesions in the cerebral cortex which 
characterize some of the vascular damage associated with TBI (McIntosh et al., 1996).
Intracranial hematoma is reportedly the most common cause of clinical morbidity and 
death in patients who suffer from TBI. The effects of this type of injury are often delayed 
because the associated brain swelling is responsible for the secondary events that lead to death in 
most cases (McIntosh et al., 1996). Following TBI brain damage due to ischemia is an important 
aspect underlying brain tissue destruction and patient death. Several factors contribute to 
decrease in brain blood flow including stretching and distortion of blood vessels, atrial 
hypotension, vasospasm, and post-traumatic changes in the cerebral microvasculature (McIntosh 
et al., 1996). Diffuse axonal injury (DAI) is caused by extensive diffuse lesions in white matter 
tracts. This type of injury is identified in 30% of all cases of TBI and is characterized by the 
diffuse degeneration of white matter (McIntosh et al., 1996). Diffuse axonal injury is particularly 
related to motor vehicle accidents and is often characterized after skull fracture, surface
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contusion or intracerebral hematoma and is one of the major causes of loss of consciousness and 
coma (McIntosh et al., 1996).
After sustaining an injury to the head, patients suffering from concussion symptoms and 
most severely injured patients continue to have residual impairments consisting of physical 
limitations, as well as cognitive, social, and behavioral limitations (Benedictus et al., 2010; 
Hartlage, et al., 2001). The most frequent cognitive impairments include mental slowness, 
attention deficits, memory restrictions, and problems with executive functioning. The main 
behavioral change after injury involves the increased frequency of aggression. (Chevignard et al., 
2009). In a study conducted by the American Congress of Rehabilitation Medicine, behavioral 
and cognitive impairments after traumatic brain injury were studied and related to outcome and 
time needed to return to work. This study concluded that almost half of the patients observed 
experienced cognitive and behavioral problems one year after injury. Even in patients with mild 
TBI, 43% experienced cognitive impairment, and one in three experienced behavioral problems 
(Benedictus et al., 2010).
Memory and learning disturbances are among the most frequently reported cognitive 
symptoms after TBI (Ariza et al., 2006). This damage is caused by a combination of direct injury 
involving diffuse axonal injury, various contusions, ischemia, as well as the neuronal tissue loss 
associated with the excitotoxic cascade. These symptoms are often hard to predict after injury 
because most memory impairments in patients with TBI are non-specific due to the diffuse 
damage incurred by the injury (Shaw, 2002). In a study conducted by the Department of 
Psychiatry and Clinical Psychobiology at the University of Barcelona, Ariza and colleagues 
analyzed experimental evidence concerning the specific location of focal lesions on the brain and 
their relationship to a specific pattern of memory impairment. The study suggests material-
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8specific memory impairment, such as facial recognition problems, may occur after trauma 
involving focal lesions, but non-specific memory impairment is prevalent after diffuse injuries 
that affect multiple areas in the brain (Ariza et al., 2006).
Executive function deficits are also a common consequence of TBI. This type of 
functioning and higher-thought processing is controlled and regulated by the frontal lobes, which 
are more commonly injured during a closed brain injury. The prefrontal cortex handles the 
processing of information in decision making, reasoning, as well as derives aspects of an 
individual’s personality (Chevignard et al., 2009; Dikmen et al., 2003). Focal damage to any of 
the cortical structures may cause development of specific disabilities; however, diffuse injury 
effects are more widespread. Motor impairment usually involves damage to the cerebellum or 
the somatosensory cortex at the pre- and postcentral gyrus. This system combines signals from 
the periphery to produce sensory modalities such as touch, temperature, and proprioception 
(Lotze et al., 2006).
Following the mechanical injury, secondary neuronal and cellular injury occurs hours to 
days after the initial trauma. This delayed injury is associated with neurochemical alterations 
which affect brain blood flow, ion homoeostasis, and metabolism (McIntosh et al., 1996). The 
initial injury also has direct toxic effects on localized neurons and glial cells.
Several types of cellular changes occur upon the impact of injury. Increased acetylcholine 
release is associated with impairment of cholinergic neurons and loss of consciousness and coma 
following TBI (McIntosh et al., 1996). The arachidonic acid cascade caused by elevated levels of 
intracellular calcium activates proteins such as phospholipase-A2, lypoxygenase and 
cycloxygenase which break down arachidonic acid into metabolites which, in turn, activate 
proteases and lipases that degrade the cell membrane of affected neurons and glial cells
(McIntosh et al., 1996). Cytokines may also have a significant function in the delayed effects of 
TBI. Congregation of leukocytes at the site of injury via cytokine signaling and possible 
disruption of the blood-brain barrier is associated with cerebral edema. Leukocytes, including 
macrophages, may have degrading affects on damaged neurons (McIntosh et al., 1996).
The most dramatic neurochemical change following trauma is the uncontrolled release of 
excitatory neurotransmitters. This efflux of chemical messengers is associated with secondary or 
delayed injury processes that develop over a period of minutes to hours and cause irreparable 
damage to sensitive neuronal tissue. This secondary injury is mediated by increased interstitial 
concentrations of excitatory amino acids, specifically glutamate and aspartate (Kim et al., 2010). 
The excessive release of these neurotransmitters causes a cascade of cellular signaling that 
eventually leads to glial swelling and neuronal cell death. In a recent study, brain injury induced 
on animal models using fluid percussion caused a marked increase in extracellular glutamate and 
aspartate surrounding the site of trauma. The concentration of these excitatory amino acids was 
relative to the severity of experimental injury (Kim et al., 2010). The uncontrolled release of 
these neurotransmitters contributes to the delayed tissue damage following injury to the brain.
Glutamate is the most abundant amino acid in the central nervous system. Sixty percent 
of all neurons utilize glutamate as their primary excitatory neurotransmitter. (Watkins and Jane, 
2006) Toxic effects caused by excessive release of glutamate, known as glutamate-induced 
excitotoxicity, cause marked changes in brain tissue physiology and result in a significant 
number of cellular disruptions including interference of ion gradients, increase in intracellular 
calcium levels and over-activation of secondary messenger systems. This massive progression of 
cellular events leads to neuronal cell death due to a variety of processes that end in apoptosis or 
necrosis. (Watkins and Jane, 2006)
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The regulation of specific ion gradients is essential to the function and continuation of 
cellular processes. After injury, ionic gradients and their respective concentrations are 
significantly altered and, consequently, a variety of harmful events proceed until the gradients 
can be restored (Hilton et al., 2006). The maintenance of intracellular calcium levels in neuronal 
tissue is an essential factor in the regulation of cell signaling events and activation of 
intracellular enzymes (Hilton et al., 2006). Total brain tissue calcium levels appear to be 
significantly elevated post-injury in experimental models of TBI (McIntosh et al., 1996). The 
subsequent over-activation of the N-methyl-D-aspartic acid (NMD A) receptor by glutamate 
causes increased expression of various genes through activation of calcium-dependent 
transcription factors and calcium-activated neutral proteases, such as calpain, which contributes 
to significant cytoskeletal degradation (McIntosh et al., 1996).
Other ions associated with neuronal cell function include magnesium, Mg2+, and sodium 
Na+. Magnesium is an essential element for several processes within the central nervous system, 
as well as glycolysis, synthesis of DNA and RNA, and maintaining integrity of mitochondrial 
and cell membranes (Hilton et al., 2006). Recent experiments have shown that the concentration 
of magnesium declines after brain trauma, causing a significant decrease in glucose metabolism 
and protein synthesis. Magnesium has also shown some effect on regulation of calcium levels 
within the cell (McIntosh et al., 1996). Sodium ions are essential for cell signaling and the 
maintenance of critical concentration gradients. After injury the excitotoxic cascade causes an 
increase in the release and concentration of excitatory amino acids into the synaptic gap, which, 
in turn, activate specific ionotropic receptors located on the cell itself or adjacent cells (McIntosh 
et al., 1996). Sodium influx through excitatory receptors causes the widespread depolarization of
neurons, and thus contributes to the influx of calcium, uncontrolled firing of action potentials, 
and activation of various cell signaling pathways (McIntosh et al., 1996).
Glutamate-induced excitotoxicity provokes uncontrolled calcium influx resulting in an 
intracellular cascade of cytotoxic events. The activated intracellular enzymes include the 
neuronal nitric oxide synthase with subsequent nitric oxide production and formation of radical 
oxygen species, damaging surrounding cells and leading to further cell death (Kim et al., 2010). 
A number of in vitro studies indicate that at high concentrations, glutamate is a potent neurotoxin 
capable of destroying neurons by apoptosis (Zhang and Bhavnani, 2005). The influx of 
extracellular ions leads to the activation of enzymes, neuronal depolarization and uncontrolled 
firing, and the failure of ion pumps and subsequent depletion of essential concentration 
gradients. In a study conducted at the University of Pittsburgh School of Medicine, researchers 
compared results of fluid percussion injury on rat cortical slices in vivo to effects of direct 
injection of NMDA and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
excitatory amino acids on the same areas studied in vivo. Researchers concluded that both 
AMPA and NMDA produced a cavitary lesion with an anatomical extent similar to that caused 
by severe TBI, as replicated by in vivo fluid percussion models (Palmer et al., 1993). The 
experimental model in my study utilizes the specificity of the AMPA excitatory amino acid to 
replicate TBI.
Glutamate acts on many different types of receptors. The classes of ionotropic glutamate- 
binding receptors include the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptor, N-methyl-D-aspartic acid (NMDA) receptor, and kainate receptor, named for chemical 
agonists of the receptor proteins. Ionotropic receptors contain associated ion-gated channels that 
are regulated by agonist binding. Together, these receptors control and modulate neural circuits
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in the brain and underlie aspects of cognitive function (Morimoto-Tomita et al., 2009). The 
receptors mediate excitatory transmission between neurons. Binding of glutamate to the AMPA 
or NMDA receptor opens post-synaptic cation channels and initiates excitatory post-synaptic 
current. Considerable experimental evident shows that AMPA and NMDA receptors co-localize 
at most functional excitatory synapses, however the ratio of AMPA to NMDA receptors varies 
greatly between different neural synapses. Kainate receptors appear in smaller numbers 
throughout regions in the central nervous system (Nestler, 2009).
The AMPA receptor is a 4-subunit protein which allows the influx of Na+ cations into the 
postsynaptic cell. Some of these receptors, specifically those that lack important features of the 
GluR-2 subunit, are also permeable to Ca2+ which allows the flow of calcium into the cell and 
subsequent activation of secondary messenger systems. These types of receptors are commonly 
found on inhibitory interneurons throughout the brain (Nestler, 2009). Allosteric modulation of 
the AMPA receptor is potentiated by binding of the specific molecule to the GluR-2 subunit, 
which in turn, regulates activity and influx/efflux of specific ions (Fukata et al., 2005). This 
receptor functions as an ion channel and is inhibited by 6-cyano-7-nitroquinoxaline-2, 3-dione 
(CNQX), a drug that competitively antagonizes AMPA receptor function. This type of drug 
permits unequivocal, experimental-separation of AMPA receptors from other categories of 
glutamate receptors (Fukata et al., 2005).
The NMDA receptor is likely to provide the most significant means by which synaptic 
activity may increase the level of postsynaptic intracellular Ca2+. Activated by glutamate or 
NMDA binding, this receptor is the predominant molecular device for synaptic plasticity and 
memory function (Nestler, 2009). This receptor is composed of a heterotetramer of two sets of 
the subunits, NR1 and NR2. The ionotropic receptor provides a channel for K+, Na+, and is
12
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highly permeable to Ca2+, however, channel function is voltage-gated by the presence of a Mg2+ 
cation that blocks the channel’s pore and corresponding movement of ions across the membrane 
upon activation (Mony et ah, 2009). As the postsynaptic membrane potential depolarizes, the 
Mg2+ is released, and depolarization is expedited by influx of Na+ and Ca2+ (Siegel, 1989). The 
NMDA receptor has several target sites for allosteric modulation by molecules resembling 
polyamines and aminoglycosides. Dizocilpine (MK-801) acts as a non-competitive antagonist of 
NMDA receptor function. N-methyl-D-aspartic acid (NMDA) receptors have been prominent 
drug targets for conditions such as stroke and head trauma in which excitotoxicity has a 
significant role (Nestler, 2009).
The kainate receptor is a glutamate-induced ionotropic receptor that provides the channel 
for influx of sodium and potassium and is located on the presynaptic cell (Siegel, 1989). The 
structure of the receptor is composed of 5 subunits which arrange to form a functioning 
membrane channel protein. This receptor provides modification and regulation of a specific 
neurotransmitter release but has a more limited distribution throughout the brain as compared to 
AMPA and NMDA receptors (Siegel, 1989).
Metabotropic glutamate receptors (mGluR) are a type of membrane protein activated in 
the presence of glutamate to initiate indirect metabotropic processes. This type of receptor 
protein is a member of the G-protein-coupled receptors, which can simultaneously activate 
multiple signaling pathways (Skeberdis et al., 2001). Activation of mGluRs initiates a variety of 
intracellular functions throughout the central nervous system. The eight different types of 
mGluRs have seven transmembrane regions which span the cell membrane and, upon activation, 
stimulate a variety of biochemical cascades which modulate the activity of other proteins, 
including the NMDA ionotropic receptor (Skeberdis et al., 2001).
The excitotoxic cascade is the most prevalent cause of delayed injury in cases of TBI. 
The excessive stimulation of ionotropic glutamate receptors is implicated in the pathogenesis of 
various neurodegenerative conditions (Shirakawa et al., 2006). However, extensive experimental 
evidence supports that neuroactive steroid compounds may modulate effects of glutamate- 
induced excitotoxicity. Although NMDA receptors have an important role in excitotoxicity due 
to their high permeability to Ca2+, over-activation of non-NMDA receptors may also contribute 
significantly to the overall effects of excessive glutamate release on neuronal cells (Shirakawa et 
al., 2006). Neurosteroids are synthesized in the central nervous system in glial support cells and 
neurons as well as throughout the periphery from cholesterol or other steroidal precursors 
imported from peripheral sources. (Baulieu, 1998) The focus of my study is on the 3p-hydroxy- 
delta-5-compounds, pregnenolone sulfate (PS) and 5-dehydroepiandrosterone sulfate (DHEAS) 
and their effects on the AMPA receptor in vitro during an AMPA-induced excitotoxic cascade. 
These steroids have been shown to modulate the inhibitory receptor, γ-aminobutyric acid A 
(GABAA), NMDA, and sigma-1 receptors (Baulieu, 1998) however, there effect on the AMPA 
receptor is relative unknown.
These neuroprotective steroids are synthesized from cholesterol and similar compounds. 
Cholesterol is synthesized locally in the brain and peripheral nerves as a source of maintenance 
for fatty myelin sheaths. Cholesterol is converted to pregnenolone by the cytochrome P450scc 
(side chain cleavage) protein (Fig. 1), which is a specific hydroxylase involved in cleaving side 
chains of cholesterol with other enzymes andernodoxin and adrenodoxin reductase by neurons 
and glial cells (Baulieu, 1998). The regulatory mechanisms for cytochrome P450scc are still 
unknown. 5-dehydroepiandrosterone (DHEA) and PREG are converted to PS and DHEAS by a 
sulfotransferase enzyme within neurons and glial cells (Baulieu, 1998).
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Figure 1: The metabolism o f neurosteroids. 
(Modified from Baulieu, 1998)
Pregnenolone and PS are the most abundant neuroactive steroids in the brain. These 
neurosteroids act as specific and potent allosteric modulators of the GABAA receptor (Shirakawa 
et al., 2005). The GABAA receptor is the primary inhibitory receptor in the brain. This ionotropic 
receptor has several allosteric sites which allow modulation of its activity upon ligand binding. 
This receptor allows the influx of chloride ions, both pre- and post synaptically into the cell, 
causing a repolarization effect. Activation of this specific receptor has shown to have anesthetic 
and anticonvulsant effects. Experimentally, PS and DHEAS have been shown to be negatively 
modulate GABAA receptor function, decreasing current across the post-synaptic membrane 
(Shirakawa et al., 2005).
In a similar experiment researchers at Kyoto University showed that PS allosterically 
potentiates the NMDA receptor activity in vitro but has an inhibitory effect on non-NMDA
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receptors. Evidence suggests that PS exacerbates neuronal cell death associated with NMDA 
excitotoxicity (Shirakawa et al., 2005). The researchers also evaluated the effect of PS and 
DHEAS on the sigma-1 receptor, an intracellular transmembrane chaperone protein that 
modulates the release of Ca2+ from the endoplasmic reticulum (Kimonides et al., 1998). It has 
been shown that DHEAS augments the effect of NMDA excitotoxicity by increasing the levels 
of intracellular Ca2+ and, thus, causes further depolarization of the membrane and over-activation 
of secondary messenger systems which lead to cell death (Shirakawa et al., 2005). The impact of 
pregnenolone sulfate (PS) and 5-dehydroepiandrosterone sulfate (DHEAS) on the NMDA, 
GABAA, and sigma-1 receptor may give insight as to how these drugs may affect the modulation 
of AMPA excitotoxicity.
Although the neurosteroids PS and DHEAS enhance NMDA receptor function during 
excitotoxicity, the effects of these compounds on the AMPA receptor are still relatively 
unknown. The AMPA receptor plays a key role in the progress of neurotoxicity during the 
cascade of glutamate release and excitatory signaling. In a study conducted at Kyoto University, 
the effect of PS, PREG, and another, similar compound, prognenolone hemisuccinate on AMPA- 
induced excitotoxicity was observed using rat cortical slice cultures. The study concluded that PS 
may attenuate AMPA excitotoxicity by inhibiting activity of the AMPA-associated channel 
protein (Shirakawa et al., 2005). In electrophysiological study, PS has been shown to decrease 
membrane depolarization caused by AMPA receptor function (Wu et al., 1998).
The purpose of this investigation was to assess the neuroprotective effects of PS and 
DHEAS on mouse cortical cell cultures in vitro by exposing cultures to increasing levels of 
AMPA-induced excitotoxicity and measuring the level of neuronal cell death by utilizing the 
lactate dehydrogenase (LDH) assay. Based on previous electrophysiological data, it was
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hypothesized that PS and DHEAS would decrease the level of neuronal cell death induced by 
AMPA receptor over-activation after exposure to increasing levels of AMPA.
Materials and Methods:
Drugs and Chemicals
Trypsin, cytosine β-D-arabinofrunasonside (Ara-C), N-methyl-D-aspartic acid (NMDA), 
dizocilpine maleate(MK-801), pregnenolone sulfate (PS), 5-dehydroepiandrosterone sulfate 
(DHEAS), Nicotinamide adenine dinucleotide (NADH), and 4-(2-hydroxyethyl)-l- 
piperazineethanesulfonic acid (HEPES) were obtained from Sigma-Aldrich Chemicals (St. 
Louis, MO, USA). Fetal Bovine Serum (FBS), Fetal Calf Serum (CS), Fetal Growth Serum 
(FGS), Hanks Balanced Salt Solution (HBSS), Modified Earle’s Media (MEM), Epidermal 
Growth Factor (EGF), penicillin and streptomycin were obtained from Fischer Scientific 
(Rocksford, IL, USA). (S)- 2-amino-3-(5-methyl-3-oxo-l,2-oxazol-4-yl)propanoic acid (AMPA) 
and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) were obtained from TOCRIS Bioscience 
(Ellisville, MO, USA). LDH standard solution consisted of Level II Control Serum (400U/L,
Cat. # C7591-50) from Pointe Scientific, purchased through Fischer Scientific (Rocksford, IL, 
USA). Drug stocks were made using PS and DHEAS in dimethyl sulfoxide (DMSO) at 10mM.
Animal Care
Swiss mice (Hilltop Lab Animals, Scottdale, PA) were housed at room temperature in a 12/12 
light-dark cycle access to food (Harlan Teklad, 22/5 Rodent Diet (8640), Madison, WI) and 
water provided ad libitum. Animals were housed in accordance with Lynchburg College 
guidelines and expectations.
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Experimental Model
The experimental model in this study involved the application of varying concentrations 
of AMPA to mouse cortical cell cultures to replicate an AMPA-mediated excitotoxic event and 
comparing the affected groups with those treated with the specific drug, either PS or DHEAS at 
varying concentrations. Twenty-four hours prior to each experiment, 250μL of media was 
removed from each well and replaced with media stock (500mL MEM media with 45mL sterile 
glucose bicarbonate solution (20mM)) supplemented with 10μM glycine (MS/gly solution). 
Days in vitro (DIV) 14-16 mixed cortical cell cultures, used in each of the experiments, were 
washed by removing 250μL of media from each well and replacing with 500μL MS/gly solution 
twice. After wash, experimental drug solutions were added to the corresponding culture wells. 
Each experimental group was compared and normalized to a blank test group (0μM AMPA) and 
a complete excitotoxic death group (300μM NMDA solution). The blank test group accounted 
for sham injury caused without exposure to the experimental conditions, as when changing 
culture media or moving cultures. Exposure to 300μM NMDA accounted for total amount of 
neuronal LDH (=100%). Neuronal cell death was measured quantitatively by the lactate 
dehydrogenase assay at 20-24 hours post-injury as described in Kho and Choi, 1987. The use of 
Swiss mouse cortical cell cultures and subsequent analysis of cell death by the LDH assay is a 
well-established technique to test induced-excitotoxicity in vitro.
Isolation and Culture o f Astrocytes
Astrocytes were isolated from 1-3 postnatal day mice, obtained from adult (2-5 month) 
females (Hilltop Lab Animals, Scottdale, PA) mated at Lynchburg College. Animals were 
sacrificed by rapid decapitation, the heads were washed twice in 70% ethanol solution to remove
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debris and transferred to a dissection dish containing a volume of dissection media (DM) (HBSS 
supplemented with sucrose, dextrose, and HEPES). The dish was kept on ice in a sterile 
horizontal flow hood. Using micro-dissection forceps, the skin and skull of subject heads were 
removed exposing the soft brain tissue. Brains were then aseptically removed from the skull and 
placed into a separate dish containing DM, meninges were removed, and the cortical tissue from 
each hemisphere was isolated from the basal forebrain, hippocampus and brainstem. Each 
hemisphere was transported to 1mL DM, mechanically minced, and placed in tube containing 
5mL dissection trypsin (0.025% trypsin in DM). The tube incubated at 35°C for 20 minutes and 
centrifuged at 1000 rpm for 5 minutes. The pellet was then triturated in a small volume of 10+10 
plating media (PM) (MEM supplemented with 20mM glucose, 10% Fetal Bovine Serum, 10% 
calf serum, 2mM L-glutamine, 50 IU/mL penicillin, 50μg/mL streptomycin and epidermal 
growth factor (10ng/mL)) and was added to a specific volume 10+10 PM (1.2 hemispheres per 
10mL PM). Four-hundred μL of the plating solution was added to each well on a 24-well plate 
and incubated at 32°C at 5%CO2. Astrocytes were fed 2-3 days after plating with 10+10 PM, and 
when cultures became confluent; the cells were inhibited with 10uL of 9μM cytosine (β-D- 
arabinofuranoside (Ara-C solution) for 4-7 days. After inhibition, inhibition chemical treatments 
were removed and replaced with growth media (GM) (Modified Earle’s Media supplemented 
with 10% calf serum, 2mM L-glutamine, and 50 IU/mL penicillin, 50μg/mL streptomycin).
Isolation and Culture o f Neurons
Neurons were isolated from fetal cortices from 15-17 prenatal day timed-gestation Swiss 
mice (Hilltop Lab Animals, Scottdale, PA). Animals were anesthetized using an isoflourane 
chamber and sacrificed by cervical dislocation. The uterus of the adult female was aseptically 
removed and transferred to a dissection dish containing a volume of DM and placed in the sterile
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horizontal flow hood. Fetuses were aseptically removed and decapitated into a new dish of DM. 
Using techniques described previously, cortices were isolated, incubated in dissection trypsin at 
35°C for 20 minutes, centrifuged and triturated in 5+5 plating media (Modified Earle’s Media 
(MEM) supplemented with 20mM glucose, 5% Fetal Bovine Serum, 5% calf serum, 2mM L- 
glutamine, 50 IU/mL penicillin, 50μg/mL streptomycin and epidermal growth factor (10ng/mL) 
and added to a specific volume 5+5 plating media (~3 hemispheres per 10mL 5+5 PM). Media 
from each well on astrocyte culture plate was replaced with the 400μL 5+5 plating media 
containing cells and incubated at 32°C at 5%CO2. Four to five days after plating, ~250μL of 
media was removed from each well of mixed astrocyte/neuron culture and replaced by 250μL of 
GM. Two days after mixed cultures were fed in 5+5 PM, the cultures were inhibited with the 
addition of 10μL Ara-C solution for two days. After that, 250μL of cell culture media was 
removed and replaced with 250μL GM. Twenty-four hours before each experiment, 250μL cell 
culture media was replaced with 250μL MS/gly solution. (See Appendix C)
AMPA and CNQX Dose Response
Drug stock solutions (4.5mL) were prepared with increasing concentrations of AMPA 
(3μM, 6μM, 9μM, 12μM) supplemented with 10μM MK-801 (Eq. 1; See Appendix A). The 
experiment was conducted by removing 500μL of media from each well and replacing media 
with 250μL of corresponding drug stock.
Drug stock solutions (3.5mL) were prepared using a constant concentration of AMPA 
(10μM) supplemented with 10μM MK-801 and increasing concentrations of CNQX (3μM, 
10μM, 30μM). Using selected mixed culture plates, each well was washed by removing 250μL
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of media and replacing with 500μL MS/gly twice. Each experiment was conducted by removing 
500μL of media from each well and replacing media with 250μL of corresponding drug stock.
AMPA Dose Response with and without PS
Drug stock solutions (2.5mL) were prepared with increasing concentrations of AMPA 
(1μM, 3μM, 9μM, 27μM). Each drug stock was supplemented with 10μM MK-801 and either 
10μM, 50μM or 100μM PS depending on the specific experiment being conducted. 
Pregnenolone sulfate was diluted from a 10mM stock solution and added to drug stocks. Drug 
stock solutions were supplemented with corresponding volumes of DMSO in absence of PS. The 
experiment was conducted by removing 500μL of media from each well and replacing media 
with 250μL of corresponding drug stock.
AMPA Dose Response with and without DHEAS
Drug stock solutions (2.5mL) were prepared with increasing concentrations of AMPA 
(1μM, 3μM, 9μM, 27μM). Each drug stock was supplemented with 10μM MK-801 and either 
10μM, 50μM or 100μM DHEAS depending on the specific experiment being conducted. 
DHEAS was diluted from a 10mM stock solution (Eq. 2) and added to drug stocks. Drug stock 
solutions were supplemented with corresponding volumes of DMSO in absence of DHEAS. The 
experiment was conducted by removing 500μL of media from each well and replacing media 
with 250μL of corresponding drug stock.
Evaluation o f Cell Death
The lactate dehydrogenase (LDH) cytotoxicity assay (Kho and Choi, 1987) was used to 
assess cell death 20-24 hours after experiment. Lactate dehydrogenase buffer was diluted from a
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sterile 10M stock solution. Nicotinamide adenine dinucleotide (NADH) solution was made using 
crystalized NADH dissolved in 1M LDH buffer at 3mg/10mL. Pyruvate solution was retrieved 
from a sterile stock solution (22.7mM). Lactate dehydrogenase buffer, NADH solution, and 
pyruvate solution were transferred to 50mL centrifuge tubes labeled correspondingly in a sterile 
environment provided by a laminar-flow hood. Supernatant (50μL) was removed from each 
experimental well on the 24-well mixed-culture plate and placed in corresponding wells on a 96- 
well microtiter plate (LDH plate). A standard curve was also plated onto the 96-well plate on 
rows G and H, columns 1-9 using corresponding volumes of the Level II control serum (400U/L) 
supplemented with PBS buffer. (Appendix B) Using a multipipette, 125μL LDH solution and 
100μL NADH solution were added to each row on the LDH plate. Pyruvate solution (50μL) was 
expediently added to each of the wells on the LDH plate, and the plate was placed in the 
spectrophotometer. Changes in optical density at 490 nm were measured using the Microquant 
by Bio-Tek Instruments. (Appendix B)
Results:
AMPA Dose Response with CNQX
Mixed cell cultures, 14-16 DIV, were exposed to increasing concentrations of AMPA 
(3μM, 6μM, 9μM, 12μM) supplemented with 10μM MK-801 to determine the effect of AMPA 
on neuronal cell death. The non-competitive NMDA antagonist MK-801 was included to block 
NMDA receptor activation by glutamate released from dead or dying neurons (Figure 2).
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Figure 2: AMPA induces a dose-dependent increase in neuronal cell death. Supernatant of 
corresponding cell cultures were collected 20-24 hours following injury and the cell death was 
quantified spectrophotometrically by measurement of LDH release. Values represent the mean ± 
S.E.M. expressed as a percentage of the total neuronal LDH (=100%), which was determined by 
exposure of sister cultures to 300μM  NMDA (n=12 cultures per condition pooled from 3 
experiments).
Application of increasing AMPA concentrations to mixed cortical cell cultures showed a 
concentration-dependent increase in neuronal cell death determined at 20-24 hours later using the 
LDH assay. This experiment served as a standard for comparison of other, similar experiments as 
well as demonstrated the effectiveness of our experimental model. The data represented in Figure 
2 shows 20% neuronal cell death after exposure to 3μM AMPA and as much as 65% neuronal 
cell death after exposure to 12μM AMPA.
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To demonstrate that this injury was AMPA-mediated, 14-16 DIV mixed cell cultures 
were exposed concurrently 10μM AMPA and an increasing concentration of CNQX (3μM,
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10μM, 30μM). Application of increasing concentrations of CNQX, a non-competitive 
antagonist of the AMPA receptor, caused a marked decrease in the neuronal cell death after 
exposure to 10μM AMPA and completely inhibited injury at 30μM CNQX.
Figure 3: CNQX blocks AMPA-mediated neuronal cell death in a dose-dependent manner. 
Supernatant of corresponding cell cultures were collected 20-24 hours following injury and the 
cell death was quantified spectrophotometrically by measurement of LDH release. Values 
represent the mean ± S.E.M. expressed as a percentage of the total neuronal LDH (=100%), 
which was determined by exposure of sister cultures to 300μM NMDA (n=12 cultures per 
condition pooled from 3 experiments).
Inhibition of the AMPA receptor by the competitive antagonist CNQX, (Fig. 3) displayed the 
specificity of modulation of excitotoxicity via the AMPA receptor. The level of cell death after
CNQX (μ M)
10μM AMPA
3 10 30
100.0 
80.0 
60.0
40.0
20.0 
0.0
-20.0
Ne
ur
on
al
 C
el
l D
ea
th
 (%
)
administration of 10μM AMPA was 74.6%, and when cell cultures were concurrently exposure 
with 10μM AMPA and increasing concentrations of CNQX, neuronal cell death noticeably 
decreased. AMPA-mediated neuronal cell death was decreased by nearly 50% after exposure to 
3μM CNQX. These experiments displayed the specificity of the experimental design for 
modulation of neuronal cell death through the AMPA receptor.
Effect o f Pregnenolone Sulfate on AMPA-mediated Cell Death
Mixed neuronal cell cultures (14-16 DIV) were exposed to increasing concentrations of 
AMPA (1μM, 3μM, 9μM, and 27μM) with or without PS (at 10μM, 50μM, or 100μM). All 
experimental conditions were concurrently treated with 10μM MK-801 to block activation of 
NMDA receptors. In addition, experimental conditions without PS treatment were supplemented 
with an equal amount of DMSO. Exposure to increasing concentrations of AMPA caused a dose- 
dependent increase in the amount of neuronal cell death. Inhibition of excitotoxicity induced by 
exposure to increasing concentrations of AMPA was evident in experimental results (Fig. 4, 5,
6). Data from AMPA dose response experiments with 10μM, 50μM and 100μM PS showed 
apparent reduction of injury as determined by LDH release provided by the addition of various 
concentrations of the selected neurosteroid, PS. The effects of PS seem to be concentration 
dependent, in that 100μM PS decreased the level of excitotoxicity to a greater extent as 
compared to 10μM  and 50μM concentrations of PS.
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Figure 4: Neuronal cell death induced by AMPA is reduced by concurrent exposure to 10μM 
PS. Supernatant of corresponding cell cultures were collected 20-24 hours following injury and 
the cell death was quantified spectrophotometrically by measurement of LDH release. Values 
represent the mean ± S.E.M. expressed as a percentage of the total neuronal LDH (=100%), 
which was determined by exposure of sister cultures to 300μM NMDA (n=11-12 cultures per 
condition pooled from 6 experiments).
The AMPA dose response with 10μM PS displayed slight inhibition of AMPA-induced 
excitotoxicity. Experimental groups treated with 10μM PS decreased the level of cell death at 3, 
9, and 27μM AMPA by 12.6, 8.9, and 9.2% respectively. The groups at 1μM AMPA without PS 
displayed 6.2% cell death, while the group treated with 10μM PS at 1μM AMPA showed a 
decrease in cell death as compared to the blank (-3.5% cell death). This is attributed to the 
amount of cell death in the sham injured groups, which was 18.7%.
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Figure 5: Neuronal cell death induced by AMPA is reduced by concurrent exposure to 50μM 
PS. Supernatant of corresponding cell cultures were collected 20-24 hours following injury and 
the cell death was quantified spectrophotometrically by measurement of LDH release. Values 
represent the mean ± S.E.M. expressed as a percentage of the total neuronal LDH (=100%), 
which was determined by exposure of sister cultures to 300pM NMDA (n=26-27 cultures per 
condition pooled from 14 experiments).
The AMPA dose response with 50μM PS showed the inhibition of AMPA-induced 
excitotoxicity. The groups treated with 50μM PS showed modulation of the AMPA receptor 
resulting in 17.1, 22.5, and 29.3% decrease in cell death at 3, 9, and 27μM AMPA respectively. 
The level of cell death incurred by 1μM AMPA was reduced to 0% with 50μM PS.
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Figure 6: Neuronal cell death induced by AMPA is reduced by concurrent exposure to 100μM 
PS. Supernatant of corresponding cell cultures were collected 20-24 hours following injury and 
the cell death was quantified spectrophotometrically by measurement of LDH release. Values 
represent the mean ± S.E.M. expressed as a percentage of the total neuronal LDH (=100%), 
which was determined by exposure of sister cultures to 300μM NMDA (n=22-24 cultures per 
condition pooled from 12 experiments).
The test groups administered with the AMPA dose response with and without 100 μM PS 
showed an apparent decrease in cell death at 3μM AMPA (36.1%), 9μM AMPA (52.6%), and 
27μM AMPA (43.4%). Increasing concentrations of AMPA caused subsequent increase in 
neuronal cell death in each of the experimental groups but in the presence of PS the amount of 
cell injury was reduced. The greatest reduction of neuronal cell death was in groups exposed to 
100μM PS.
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Effect o f Dehydroepiandrosterone Sulfate on AMPA-mediated Cell Death
Mixed neuronal cell cultures (14-16 DIV) were exposed to increasing concentrations of 
AMPA (1μM, 3μM, 9μM, and 27μ M) with or without DHEAS (at 10μM, 50μM, or 100μM).
All experimental conditions were concurrently treated with 10μM MK-801 to block activation of 
NMDA receptors. Experimental conditions without DHEAS treatment were supplemented with 
an equal amount of DMSO. Exposure to increasing concentrations of AMPA caused a dose- 
dependent increase in the amount of neuronal cell death. Figure 7, 8, and 9 represent the results 
of the LDH assay for the AMPA dose response with 10μM, 50μM, and 100μM DHEAS, 
respectively. Data from AMPA dose response experiments with 10μM DHEAS showed a no 
apparent reduction of neuronal cell death provided by the addition of 10μM  of the selected 
neurosteroid, DHEAS (Fig. 7). However at higher concentrations of DHEAS, the reduction of 
neuronal cell death as determined by LDH release was more apparent. There is a slight decrease 
in AMPA-induced excitotoxicity in groups exposed to 50μM DHEAS (Fig. 8), and a more 
noticeable decrease in the percentage of cell death in groups administered with 100μM DHEAS 
(Fig. 9).
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Figure 7: Low concentrations of DHEAS (10μM) have no effect on AMPA-induced neuronal 
cell death. Supernatant of corresponding cell cultures were collected 20-24 hours following 
injury and the cell death was quantified spectrophotometrically by measurement of LDH release. 
Values represent the mean ± S.E.M. expressed as a percentage of the total neuronal LDH 
(=100%), which was determined by exposure of sister cultures to 300μM NMDA (n=6 cultures 
per condition pooled from 3 experiments).
The results of this experiment (Fig. 8) display a slight increase in cell death at 10μM 
DHEAS. The occurrence of cell death in each test group increased by at least 5% at every 
concentration tested, suggesting that lower concentrations of DHEAS has no affect on reduction 
of AMPA-induced excitotoxicity. The cell death caused by 1μM AMPA solutions increased 
8.2% with exposure to 10μM DHEAS.
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Figure 8: DHEAS (50μM) concurrent with AMPA caused minimal reduction in neuronal cell 
death. Supernatant of corresponding cell cultures were collected 20-24 hours following injury 
and the cell death was quantified spectrophotometrically by measurement of LDH release. 
Values represent the mean ± S.E.M. expressed as a percentage of the total neuronal LDH 
(=100%), which was determined by exposure of sister cultures to 300μM NMDA (n=8 cultures 
per condition pooled from 4 experiments).
The results of this experiment (Fig. 9) display a decrease in AMPA-induced cell death 
with concurrent exposure to 50μM DHEAS. This concentration of DHEAS appeared to slightly 
decrease the percentage of cell death induced by exposure to increasing concentrations of 
AMPA. A decrease in cell death by at least 10% was observed in test groups administered with 
1μM and 3μM AMPA, with 7.8% decrease in cell death noted at 9μM AMPA, and 12.2% 
decrease in cell death at 27μM AMPA.
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Figure 9: AMPA-induced neuronal cell death is reduced by DHEAS (100μM) Supernatant of 
corresponding cell cultures were collected 20-24 hours following injury and the cell death was 
quantified spectrophotometrically by measurement of LDH release. Values represent the mean ± 
S.E.M. expressed as a percentage of the total neuronal LDH (=100%), which was determined by 
exposure of sister cultures to 300μM NMDA (n=10 cultures per condition pooled from 5 
experiments).
The results of this experiment (Fig. 10) display the decrease in AMPA-induced cell death 
with concurrent exposure to 100μM DHEAS. Higher concentrations of DHEAS (100μM) 
appeared to show a larger decrease in the amount of cell death at all concentrations of the AMPA 
dose response. The level of cell death decreased 4.3% at 1μM AMPA, and 6.3% in groups 
exposed to 27μM AMPA. Neuronal cell death was decreased by at least 15% in groups tested 
with 3μM AMPA and 9μM AMPA.
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Discussion:
Traumatic brain injury is replicated in vitro utilizing cortical cell cultures in this study to 
isolate the activity of the specific glutamate receptor, AMPA. Using cortical cell cultures as 
opposed to in vivo tests allows more control of experimental conditions and consequently 
increased data specificity with reference to the modulation of AMPA receptor function when 
concurrently exposed to agonist and neurosteroid. AMPA-receptor specific modulation by the 
neurosteroid PS appears to be dose-dependent, as the increase in protection corresponds with the 
increase in concentration of PS. Pregnenolone sulfate provides protection from AMPA-induced 
toxicity via the modulation of the AMPA receptor in all trials (Fig. 5, 6, and 7). At higher 
concentrations, the neurosteroid dehydroepiandrosterone sulfate displayed a similar, but smaller 
effect. Both 50μM and 100μM concentrations of DHEAS decreased neuronal cell death after 
concurrent exposure of cell cultures to the neurosteroid and AMPA dose response (Fig. 9 and 
10). At lower concentrations of DHEAS, no noticeable decrease in neuronal cell death elicited by 
increasing concentrations of AMPA was observed. The original hypothesis proposed in this 
study, based on previous electrophysiological data (Wu et al., 1998), was that PS and DHEAS 
would decrease the level of neuronal cell death induced by AMPA receptor over-activation and 
according to experimental evidence gathered from this study, PS and higher concentrations of 
DHEAS decreased the level of cell death caused by increasing concentrations of AMPA.
As compared to PS, DHEAS is not as effective in providing protection from 
excitotoxicity via AMPA-receptor modulation. In conclusion, our experimental data indicate the 
receptor-specific modulation of AMPA by increasing levels of PS decreases the amount of 
neuronal cell death in mixed cell cultures and the neurosteroid, DHEAS provides a lesser degree 
of excitotoxic protection at higher concentrations. The neuroprotective effect of PS against
AMPA neurotoxicity suggests that this neuroactive steroid acts as an endogenous regulatory 
factor in the central nervous system pathology involving AMPA receptor-mediated excitotoxic 
events (Shirakawa et al., 2005). Further research into the exact mechanism of the neurosteroid is 
suggested in order to develop a treatment method for detrimental excitotoxic events following 
TBI.
The first experiment conducted observed how increasing the concentration of AMPA 
induced neuronal cell death (Fig. 3). The next experiment involving inhibition of the AMPA 
receptor by the non-competitive antagonist CNQX, (Fig. 4) displayed the specificity of 
modulation of excitotoxicity via the AMPA receptor. Specific inhibition of the receptor caused a 
marked decrease in levels of LDH and thus a decrease in the level of cell death. The level of cell 
death after administration of 10μM AMPA was 74.6%, and when paired with increasing 
concentrations of CNQX, cytotoxicity noticeably decreased in a dose-dependent manner and at 
30μM CNQX, neuronal cell death caused by 10μM AMPA was completely inhibited. The effect 
of CNQX and increasing concentrations of AMPA on mixed cortical cell cultures is evident in 
literature. (Morimoto-Tomita et al., 2009; Fukata et al., 2005) These experiments exemplified the 
specificity of our experimental model in the modulation of AMPA-regulated events.
The lactate dehydrogenase (LDH) cytotoxicity assay was used to assess cell death 20-24 
hours after experimental treatments. The prevalence of LDH in the supernatant is directly 
comparable to the level of cell death. Lactate dehydrogenase is a cytosolic enzyme that is 
released upon cell death and lysis of the cell membrane. Extracellular LDH is both chemically 
and biologically stable; the magnitude of LDH efflux in the cultures correlates in a linear fashion 
with the number of neurons damaged by glutamate exposure (Kho and Choi, 1987). The LDH
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assay is a well-established procedure for quantification of excitotoxicity in vitro (Kho and Choi, 
1987; Minor, 2006).
This study focuses on observing modulation of the neurosteroids PS and DHEAS on the 
AMPA receptor; however the AMPA receptor is only one part of a very complicated system 
affected by glutamate excitotoxicity. The function of the AMPA receptor is shown to be 
negatively modulated upon exposure to the neurosteroid PS; however the NMDA receptor, 
another major ionotropic receptor activated by glutamate, is inversely affected. 
Electrophysiological studies have suggested NMDA activation is increased upon exposure to the 
neurosteroid PS, allowing further depolarization of the neuronal cell membrane (Wu et al., 1998) 
and consequently increasing levels of neuronal cell death. Higher concentrations of PS (100μM) 
have been shown to increase neuronal cell death in vitro 10-15% after a 24-hour concurrent 
exposure with NMDA (Melchior and Muir, 2010). Electrophysiological studies of the affect of 
PS on the kainate receptor also suggest that activity of the kainate receptor is inhibited upon 
exposure to the neurosteroid PS, causing a decrease in the depolarization of the membrane 
incurred by agonist binding (Wu et al., 1998). There is a wide range of glutamate receptors 
activated by the uncontrolled release of the excitatory neurotransmitter during TBI that elicit a 
combination of downstream events including modulation of membrane potentials, disruption of 
specific ionic gradients, and activation of secondary messenger systems. This experimental 
evidence exemplifies the complexity of neuronal communication and modulation of the events 
following trauma to the brain.
Concentrations of PS required to attenuate AMPA neurotoxicity in vitro were much 
higher than those reported in adult-normal rat brain, in human plasma and in aged human brain 
tissue. However, synthesis and release of neuroactive steroids may be reinforced under several
pathological conditions including cerebral ischemia, epilepsy and depression, and prove to be a 
viable target for drug synthesis (Shirakawa et al., 2005). Further research in the field of TBI is 
required to understand the specific mechanisms that lead to disabilities and death in order to 
develop both therapeutic action and preventative treatment at the cellular level. Continued 
research in the study should include different models of measuring the level of cell death 
including cortical slice cultures and Nissl staining, as is evident in similar research. In addition 
other, prospective neurosteroids should be included in hope of providing a substantial evidence 
of neuroprotection to elicit the development of a drug treatment method to decrease delayed 
injury following TBI. The time course of excitotoxicity may also be a subject of future 
investigation, as suggested by this study. Delayed injuries continue to cause problems with 
cognitive function and mental abilities following an injury to the brain, consequently the 
characterization of secondary injury factors and specific biomechanical operations will further 
provide insight into treatment and therapy for those who suffer from TBI.
Animal research is an essential part of biomedical research and has a vital role in 
discovery and development of cures and therapeutic treatment for human diseases. The use of 
rodent, specifically mouse, models in biomedical research is ideal due to the anatomical and 
physiological similarities between rodents and humans. Virtually every major medical advance 
involving human disease and disability has been achieved through biomedical research involving 
animal models. Continued basic research is needed to fully understand the incredibly 
complicated mechanisms underlying pathology of traumatic brain injury in order to develop safe 
and effective treatment methods of patients who suffer from TBI.
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Appendix A:
Experimental Calculations and Details:
Equation 1:
Calculation final volumes of corresponding drug concentrations from stock solutions. 
M1V1=M2V2
4500μL * 10μM  MK-801 = 2000μM MK-801 * V2 
V2= 22.5μL MK-801 solution
4500μL * 3μM AMPA = 10000μM AMPA * V2 
V2= 1.35μL AMPA solution
Chart of respective volumes in each drug solution for the AMPA DR with 100μM PS experiment
A M P A  DR w ith  1 0 0 μ M  PS f r o m  1 1 /1 5 /1 0
C o n c e n tra t io n  
o f  A M P A
V o lu m e  A M P A  
S to c k  ( 1 0 μ M )
V o lu m e  M K -8 0 1  
S to c k (2 m M )
V o lu m e  o f  PS 
S to c k (1 0 m M )
D M SO
( w /o  PS T re a tm e n t)
T o ta l V o lum e
o f D ru g  S to c k
0 0μL 1 2 .5 μ L 2 5 μL 2 5 μ L 2 .5 m L
1 0 .2 5 μ L 1 2 .5 μ L 2 5 μ L 2 5 μ L 2 .5 m L
3 0 .7 5 μ L 1 2 .5 μ L 2 5 μ L 2 5 μ L 2 .5 m L
9 2 .2 5 μ L 1 2 .5 μ L 2 5 μ L 2 5 μ L 2 .5 m L
27 6 .7 5 μ L 1 2 .5 μ L 2 5 μ L 2 5 μ L 2 .5 m L
300μ M
N M D A 4 .5 m L
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Appendix B:
LDH Assay Details:
LDH Standard Curve
Concentration 
of Enzyme
PBS
(μL)
Enzyme
(μL)
0 40 0
25 37.5 2.5
50 35 5
75 32.5 7.5
100 30 10
150 25 15
200 20 20
300 10 30
400 0 40
LDH standard curve was plotted on a chart. R-squared value maintained above 0.94 and recorded 
to ensure accuracy of results as compared to the standards.
LDH Results from 10/31/10: AMPA DR with and without 50μM PS.
Condition 1 2 3 4 5 6 7 8
Blank 10 26 22.465 22.465
Full Kill 183.07 172.3 211.47 157.61 160.55 192.87 138.02 234
1AMPA 71.431 66.535 71.431 49.886
+ 50 PS 66.535 53.803 53.803 52.824
3AMPA 149.78 146.84 166.43 155.65
+ 50 PS 120.4 147.82 143.9 170.34
9AMPA 137.05 156.63 150.76 149.78
+ 50 PS 147.82 122.36 135.09 157.61
27AMPA 147.82 156.63 157.61 154.67
+ 50 PS 120.4 152.71 125.29 141.94
BK, 50PS 31.279 35.197 42.052 30.3
Enzyme used was Level II 
Control Serum
Plate # 1
RAW DATA
Plate # 2
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The data derived from each test well was averaged and normalized with the full kill solution. 
After normalizing the data, the blank, accounting for sham injury, or LDH release not associated 
with exposure to experimental conditions, was subtracted from each test group so that the blank 
tests represented 0% cell death, and the 300μM NMDA, full kill, test group (100% cell death).
NORMALIZED
(-BLANK)
Mean SD SE
Blank 0 0
Full Kill 100.0 0.0 0.0
1AMPA 6.2 10.0 2.9
+10 PS -3.5 9.1 2.6
3AMPA 47.8 16.2 4.7
+10 PS 35.1 10.7 3.1
9AMPA 89.4 5.4 1.6
+10 PS 80.5 7.3 2.1
27AMPA 89.6 11.2 3.2
+10 PS 80.4 11.5 3.3
BK, 10PS -9.1 4.5 1.3
The normalized data was plotted on a column 
graph and analyzed following each 
experimental procedure.
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Appendix C:
Pictured are mixed astrocyte-neuron cell cultures viewed under a light microscope. The 
photograph left is a grouping of neuronal cell bodies (grey surrounded by a white halo) with 
neuritis (dark, branch-like extensions) extending in different directions. This picture is at 40x 
magnification. Right is several groupings of neuronal cell bodies, with a good view of the 
underlying astrocyte bed (darker grey, resembling cobble stones). The neurons require the 
plating of astrocytes in this experimental model to support the livelihood of the neurons as well 
as regulate their external environment. This picture is at 20x magnification. The induction of 
injury by selected concentration of AMPA causes the noticeable degeneration and destruction of 
neuritis and neuronal cell bodies through visual observation under a light microscope in a dose
dependent manner.
